Evidence map›Paper›PMID 27863385›Full record

ArticleOncotarget2016

Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling.

Chuan Zhang, Yong Wang, YiFei Feng, Yue Zhang, Bing Ji, Sen Wang, Ye Sun, Chunyan Zhu, Dongsheng Zhang, Yueming Sun

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The Roles of Zinc Finger Proteins in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chuan ZhangColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Yong WangColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
YiFei FengColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Yue ZhangColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Bing JiColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Sen WangColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Ye SunColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Chunyan ZhuColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Dongsheng ZhangColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Yueming SunColorectal Department of the First Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu CHINA, 210029.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer(CRC) is one of the most commonly diagnosed cancers in human beings and metastasis is the main death reason. Recently, Gli1 has been reported to be a key regulator of various cancer biologies and genes expressions. However, the detailed molecular mechanism of Gli1 in CRC metastasis remains largely unknown. In this study, we aimed to investigate the role of Gli1 in CRC metastasis. We used qRT-PCR, Immunohistochemistry and Western blot to test the expression levels of Gli1, Foxm1 and other target genes in the tissues and cells; Lentivirus stable transfection to change the expression levels of Gli1 and Foxm1; Wound-healing, cell invasion, migration assays and tail vein metastatic assay to test the role of Gli1 in CRC metastasis in vitro and vivo. We demonstrated that Gli1 was significantly overexpressed in colorectal cancer tissues and cells. Foxm1 level had a positive correlation with Gli1. Furthermore, we found that Gli1 promotes colorectal cancer cells metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling. Thus, we proved that Gli1 plays important role in CRC metastasis and provided a new visual field on the therapy of CRC metastasis.

Indexed as

Epithelial-Mesenchymal TransitionAdultAgedAnimalsCell Line, TumorColorectal NeoplasmsErbB ReceptorsFemaleForkhead Box Protein M1HumansMaleMiceMiddle AgedNeoplasm MetastasisPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktErbB ReceptorsForkhead Box Protein M1FOXM1 protein, humanGLI1 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktZinc Finger Protein GLI1colorectal cancerepithelial-to-mesenchymal transitionGli1metastasisPI3K-AKT signaling

Identifiers

PMID27863385
PMCPMC5349902
OpenAlexW2550072954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.